LUPIN LTD. - The Company Plans To Carve Out, Its Trade Generics Business In India, As A Going Concern, On A Slump Sale Basis, To Lupin Life Sciences Limited, Wholly Owned Subsidiary Of The Company.
Download 
|
< Back |
| 22 Mar 2024 | |
| The Company plans to carve out, its trade generics business in India, as a going concern, on a slump sale basis, to Lupin Life Sciences Limited, wholly owned subsidiary of the Company. | |
| View all announcements for LUPIN LTD. | Source: BSE India |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback